Aperfeiçoar a troca de informações de alta qualidade entre os diferentes atores em saúde para garantir que o melhor conhecimento clínico disponível seja usado para fornecer cuidados de saúde eficazes numa população e transmitir as competências teóricas para o conhecimento do tracoma e seu controle para a eliminação da doença como causa de cegueira.
Promover a formação de recursos humanos qualificados com o intuito de reforçar as principais medidas de controle da doença, no momento em que os países membros da OMS estão buscando a eliminação da esquistossomose enquanto problema de saúde pública
This course will help you:
- In assessing whether the introduction of pneumococcal vaccine into the immunization program is cost-effective and feasible;
- In designing and implementing a vaccine introduction plan when the evidence supports the introduction;
- In monitoring the implementation and evaluating the impact after introducing the vaccine.
- Know basic concepts regarding pneumococcal epidemiology, transmission, and distribution;
- Identify those groups most susceptible to pneumococcal disease;
- Recognize the importance of pneumococcal disease as a public health problem;
- Understand pneumococcal disease burden and how it varies between developing and developed countries;
- Distinguish characteristics of specific pneumococcal disease syndromes.
- Describe practical methods for collecting surveillance data;
- Understand how surveillance data guide decisions related to pneumococcal vaccine introduction;
- Learn how to use surveillance data to estimate disease burden.
- Recognize the main types of pneumococcal vaccines;
- Understand the ways in which the PCV-7 vaccine prevents pneumococcal infections;
- Estimate the potential impact of pneumococcal vaccine introduction in your country.
- Evaluate data to choose the most appropriate vaccine;
- Determine financing options;
- Assess the capacity needs of the health system;
- Recognize procurement and regulatory needs;
- Support advocacy and communication activities.
- Understand the different methods for evaluating the economics of health interventions, such as introducing a new vaccine;
- Understand how to use a cost-effectiveness analysis (CEA) to measure the costs and benefits of introducing a rotavirus vaccine;
- Identify the main drivers of CEA for a rotavirus vaccine;
- Conduct a cost analysis for introducing a rotavirus vaccine.
- Define the rationale for advocacy on rotavirus vaccines;
- Prepare tools for spreading advocacy messages;
- Identify different audiences for outreach;
- Plan for crisis communications.
- Monitor the reach of the rotavirus immunization program through recording immunization coverage;
- Evaluate the impact of the rotavirus immunization program through monitoring disease incidence.
